Replies to post #28630 on Ocata Therapeutics Inc fka OCAT

[raijin]

I'm with zoobadooba. This is a company with zero treatments past phase 2 in development and as it stands right now they have almost a 180 million dollar market cap. Say the trials are a success and this shoots up to .50 or beyond that would make this a 540 million dollar company that has zero revenue from products and is still at least 2-3 years away from having a product that could bring in revenue. I think an R/S is inevitable; it just won't happen in the short term.